Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Cysteamine
Drug ID BADD_D00556
Description Cystinosis is a rare disease caused by mutations in the CTNS gene that encodes for cystinosin, a protein responsible for transporting cystine out of the cell lysosome. A defect in cystinosin function is followed by cystine accumulation throughout the body, especially the eyes and kidneys.[A218721] Several preparations of cysteamine exist for the treatment of cystinosis manifestations, some in capsule form, and others in ophthalmic solution form.[L15606,L15616] In particular, cystine deposits on the eye can cause significant discomfort throughout the day and require frequent treatment with eye drops, typically every waking hour.[L15611] On August 25th 2020, the first ophthalmic solution for cystinosis requiring only 4 daily treatments was granted FDA approval.[L15606] Cysteamine eye drops are a practical and effective option for those affected by ocular cystinosis. Marketed by Recordati Rare Diseases Inc., CYSTADROPS® reduce the burden of multiple frequent medications normally administered to those with cystinosis.[L15601]
Indications and Usage The bitartrate salt of cysteamine is used for the oral treatment of nephropathic cystinosis and cystinuria in children 6 years old and above, and adults.[L15616] The hydrochloride salt, used in eye drop preparations, is indicated for the treatment of corneal cystine crystal accumulation in patients with cystinosis.[L15601,L15606]
Marketing Status approved; investigational
ATC Code A16AA04; S01XA21
DrugBank ID DB00847
KEGG ID D03634
MeSH ID D003543
PubChem ID 6058
TTD Drug ID D0V0LB
NDC Product Code Not Available
UNII 5UX2SD1KE2
Synonyms Cysteamine | beta-Mercaptoethylamine | beta Mercaptoethylamine | Mercaptoethylamine | Mercamine | Mercaptamine | 2-Aminoethanethiol | 2 Aminoethanethiol | Cysteinamine | Cystagon | Cysteamine Bitartrate | Bitartrate, Cysteamine | Cysteamine Tartrate (1:1) | Cysteamine Tartrate | Tartrate, Cysteamine | Cysteamine Dihydrochloride | Dihydrochloride, Cysteamine | Cysteamine Hydrochloride | Hydrochloride, Cysteamine | Cysteamine Maleate (1:1) | Cysteamine Tosylate | Tosylate, Cysteamine | Cysteamine, 35S-Labeled | 35S-Labeled Cysteamine | Cysteamine, 35S Labeled | Becaptan | Cysteamine Hydrobromide | Hydrobromide, Cysteamine
Chemical Information
Molecular Formula C2H7NS
CAS Registry Number 60-23-1
SMILES C(CS)N
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Mood swings19.04.03.001--Not Available
Muscle spasms15.05.03.0040.000210%
Nausea07.01.07.0010.004697%
Nephrotic syndrome20.05.01.0020.000315%
Nervous system disorder17.02.10.001--Not Available
Nervousness19.06.02.003--Not Available
Neuropathy peripheral17.09.03.0030.000210%Not Available
Nightmare19.02.03.0030.000210%Not Available
Ocular hyperaemia06.04.05.0040.002496%Not Available
Optic neuritis10.02.01.097; 17.04.05.001; 06.04.08.002--Not Available
Pain08.01.08.0040.002244%
Pain in extremity15.03.04.010--
Papilloedema17.07.02.004; 24.03.07.001; 06.09.02.002--
Parosmia22.04.03.007; 17.04.04.0020.000210%Not Available
Photophobia17.17.02.006; 06.01.01.0040.000713%
Pulmonary oedema22.01.03.003; 02.05.02.0030.000210%
Pyrexia08.05.02.0030.000566%
Rash23.03.13.001--Not Available
Rash pruritic23.03.13.0300.000210%Not Available
Renal failure20.01.03.005--Not Available
Scoliosis15.10.04.001--
Seizure17.12.03.001--
Skin disorder23.03.03.007--Not Available
Skin fragility23.03.03.009--Not Available
Skin odour abnormal23.03.03.0120.000461%
Skin striae23.01.05.002--Not Available
Somnolence19.02.05.003; 17.02.04.006--
Tachycardia02.03.02.0070.000315%Not Available
Tension19.06.02.005--Not Available
Thinking abnormal19.10.03.001; 17.02.05.023--Not Available
The 3th Page    First    Pre   3 4 5    Next   Last    Total 5 Pages